Table 4.
First author, year | Country | Outcome | Control period sample | Pandemic period sample | Percentage change (95% CI, p-value)a |
---|---|---|---|---|---|
Ahmed 202134 | Bangladesh | Children Vaccinated | NR | NR | March 2020: −13.5%, April 2020: −50.4% |
Arsenault 202234 | Nepal | Childhood immunization programs | NR | NR | BCG: −45.7% (−58.3, −33.2) Pentavalent: −49.3% (−60.0, −38.6) Pneumococcal: −43.6% (−53.5, −33.7) MR: −49.0% (−60.7, −37.4) |
Golandaj 202238 | India | Paediatric TB notifications | Pre-lockdown 2020: 5539 | Pre-lockdown 2020: 7334 | Pre-lockdown 2020: +32.4% |
Lockdown 2020: 3888 | Lockdown 2020: 2953 Post- |
Lockdown 2020: −24.0% | |||
Post-lockdown 2020: 9821 | Post-lockdown 2020: 6251 | Post-lockdown 2020: −36.4% | |||
Hanifi 202140 | Bangladesh | Monthly immunization outreach sessions | In 2019, 99% of 86 monthly outreach sessions conducted | March 2020: 74% conducted | March 2020: −26% |
April 2020: 10% conducted | April 2020: −90% | ||||
May 2020: 3% conducted | May 2020: −97% | ||||
Jayatissa 202142 | Sri Lanka | Wasting prevalence | 15/109 (13.7%) | 20/109 (18.3%) | +4.6% (p > 0·05) |
Stunting prevalence | 13/109 (11.9%) | 16/109 (14.7%) | −2.8% (p > 0·05) | ||
Khan 202144 | India | Mean total vaccine count | 1311.14 (range: 932–1480) | 1051 (range: 356–1803) | April 2020: −87.7% (p < 0.001) |
May 2020: −67% | |||||
June 2020: −33% | |||||
July 2020: +27% (p = 0.228) | |||||
Kinikar 202145 | India | Mean number of childhood vaccinations per week | OPV: 86.1 | OPV: 30.8 | OPV: −55.3 |
Pentavalent: 67.7 | Pentavalent: 24.8 | Pentavalent: −42.9 | |||
Rota vaccine: 64.8 | Rota vaccine: 24.0 | Rota vaccine: −40.8 | |||
IPV: 46.6 | IPV: 18.4 | IPV: −28.2 | |||
MR: 29.6 | MR: 10.9 | MR: −18.7 | |||
Rana 202151 | Bangladesh | Childhood immunization programs | 2019: 16,524 | 2020: 15,505 | −6.2% |
April–May 2019: 2746 | April–May 2020: 2183 | −20.5% | |||
July–October 2019: 5562 | July–October 2020: 5561 | 0% | |||
Singh 202153 | India | Childhood immunization programs | NR | NR | BCG −12.2% OPV −24.6% MR 1st −28.0% JE −28.3% MR 2nd −31.6% TD −20.8% |
Where available, p-values and confidence intervals are reported. NR = not reported. Abbreviations: BCG, Bacillus Calmette–Guérin; IPV, inactivated poliovirus vaccine; JE, Japanese encephalitis; MR, measles rubella; OPV, Oral poliovirus vaccine; TD, Tetanus and Diphtheria.